PDIA4 is upregulated in RCC, and Sal treatment downregulation of PDIA4 suppressed activating transcription factor 4 (ATF4) and its downstream protein SLC7A11, thereby inactivating GPX4 and promoting ferroptosis. Here, PDIA4 is linked to renal cell carcinoma.